Improved antibody breadth with an extended primary dose interval of COVID-19 vaccine is overcome by boosters

IntroductionDuring rollout of mRNA-based COVID-19 vaccines, several jurisdictions extended the interval between the first and second doses to prioritize wider population access to limited vaccine supply. This study evaluated the effects of an extended dose interval on development of antibody and cel...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jessica I. Ahmed, Samantha J. Krosta, Mandy N. Reimer, Winnie Cheung, Christine Mesa, Carmen Lopez, Rayeil J. Chua, Farah Alsattari, Alyssia Robinson, Kathy Manguiat, Naima Jahan, Bernard Abrenica, Angela Harris, Karla Cachero, Rissa Fabia, Jonathan Walker, Myo Minn Oo, Derek Stein, Hezhao Ji, Ruey-Chyi Su, Paul J. McLaren, Lyle R. McKinnon, T Blake Ball, Heidi Wood, John Kim, Sandra A. Kiazyk, Catherine M. Card
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-03-01
Series:	Frontiers in Immunology
Subjects:	COVID-19 mRNA vaccine dose interval antibody breadth neutralization
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1529134/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Improved antibody breadth with an extended primary dose interval of COVID-19 vaccine is overcome by boosters

Similar Items